Beovu is approved for treatment of wet age-related macular degeneration.
Beovu is a medication injected into the eye to treat wet AMD. Its mechanism of action is similar to Eylea, Lucentis and Avastin. It binds to VEGF like Lucentis. Studies have shown that it is equivalent to Eylea for maintaining and improving vision but may not need to be given as frequently.